Oligodendroglioma Clinical Trials in Philadelphia, Pennsylvania
3 recruitingPhiladelphia, Pennsylvania
Showing 1–3 of 3 trials
Recruiting
Phase 2
Study of Olutasidenib and Temozolomide in HGG
Metastatic Brain TumorIDH1 MutationAstrocytoma, Grade IV+16 more
Rigel Pharmaceuticals60 enrolled20 locationsNCT06161974
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
GliomaAstrocytoma, IDH-Mutant, Grade 2Astrocytoma, Grade IV+5 more
Nuvation Bio Inc.365 enrolled55 locationsNCT05303519
Recruiting
Phase 2
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
GliomaOligodendrogliomaAstrocytoma+1 more
Stephen Bagley, MD, MSCE55 enrolled1 locationNCT05345002